Citations (26)
Keep up to date with the latest research on this topic with citation updates for this article.
Articles from other publishers (26)
Amro M. Hassan, Mustafa Ahmed Haridy, Mohamed Z. Shoaeir, Tarek M. Abdel-Aziz, Mohamed Khairy Qura, Eglal M. Kenawy, Tarek Mohamed M. Mansour, Sameh Salaheldin Elsayed, Wael Esmat Ali, Mona Mohamed Abdelmeguid & Muhammad Abdel-Gawad. (2023) Non-alcoholic fatty liver disease is associated with decreased bone mineral density in upper Egyptian patients. Scientific Reports 13:1.
Crossref
Crossref
Shaobo Wu, Yao Wu, Lan Lin, Changshun Ruan, Fang Li, Rong Chen, Hongxin Du, Xianxiang Zhang & Xiaohe Luo. (2023) Osteoprotegerin deficiency aggravates methionine–choline-deficient diet-induced nonalcoholic steatohepatitis in mice. Scientific Reports 13:1.
Crossref
Crossref
Qiang Wang, Feng Xu, Jiong Chen, Yan-Qing Xie, Su-Ling Xu & Wen-Ming He. (2023) Serum Leukocyte Cell-Derived Chemotaxin 2 (LECT2) Level Is Associated with Osteoporosis. Laboratory Medicine 54:1, pages 106-111.
Crossref
Crossref
Yuan-Wei Zhang, Mu-Min Cao, Ying-Juan Li, Xiang-Xu Chen, Qian Yu & Yun-Feng Rui. (2022) A narrative review of the moderating effects and repercussion of exercise intervention on osteoporosis: ingenious involvement of gut microbiota and its metabolites. Journal of Translational Medicine 20:1.
Crossref
Crossref
Ruijie Xie, Ya Zhang, Tao Yan, Xiongjie Huang, Songlin Xie, Changxiong Liu & Mingjiang Liu. (2022) Relationship between nonalcoholic fatty liver disease and bone mineral density in adolescents. Medicine 101:41, pages e31164.
Crossref
Crossref
Binjing Pan, Junxin Yan, Pingping Zhao, Jingfang Liu & Songbo Fu. (2021) Relationship between nonalcoholic fatty liver disease and bone mineral density in type 2 diabetic patients. International Journal of Diabetes in Developing Countries 42:4, pages 765-774.
Crossref
Crossref
Yawei Fu, Hu Gao, Xiaohong Hou, Yue Chen & Kang Xu. (2022) Pretreatment with IPA ameliorates colitis in mice: Colon transcriptome and fecal 16S amplicon profiling. Frontiers in Immunology 13.
Crossref
Crossref
Ilias D. Vachliotis, Athanasios D. Anastasilakis, Antonis Goulas, Dimitrios G. Goulis & Stergios A. Polyzos. (2022) Nonalcoholic fatty liver disease and osteoporosis: A potential association with therapeutic implications. Diabetes, Obesity and Metabolism 24:9, pages 1702-1720.
Crossref
Crossref
Juan Du, Yan Ma, Hongmei Lang, Changquan Huang & Xingping Zhang. (2022) The association of nonalcoholic fatty liver disease with bone mineral density in type 2 diabetes. European Journal of Medical Research 27:1.
Crossref
Crossref
XinChao Lin, HongTao Guo, YiGang Lian, Jiajing Kou, GuangLei Wang, YiYun Chen, Juan Wang, Xu Han, Miao Jiang & QiaoHui Yang. (2022) Osteoporosis and Related Health Status Among the Elderly Urban Residents in Elderly-Care Inns in Beijing, a Multicenter DXA Survey. Frontiers in Endocrinology 13.
Crossref
Crossref
Madalena Von-Hafe, Marta Borges-Canha, Catarina Vale, Ana Rita Leite, João Sérgio Neves, Davide Carvalho & Adelino Leite-Moreira. (2022) Nonalcoholic Fatty Liver Disease and Endocrine Axes—A Scoping Review. Metabolites 12:4, pages 298.
Crossref
Crossref
Ruijie Xie & Mingjiang Liu. (2022) Relationship Between Non-Alcoholic Fatty Liver Disease and Degree of Hepatic Steatosis and Bone Mineral Density. Frontiers in Endocrinology 13.
Crossref
Crossref
Marina V. Maevskaya, Yulia V. Kotovskaya, Vladimir T. Ivashkin, Olga N. Tkacheva, Ekaterina A. Troshina, Marina V. Shestakova, Valeriy V. Breder, Natalia I. Geyvandova, Vladimir L. Doshchitsin, Ekaterina N. Dudinskaya, Ekaterina V. Ershova, Khava B. Kodzoeva, Ksenia A. Komshilova, Natalia V. Korochanskaya, Alexander Yu. Mayorov, Ekaterina E. Mishina, Maria Yu. Nadinskaya, Igor G. Nikitin, Nana V. Pogosova, Aida I. Tarzimanova & Minara Sh. Shamkhalova. (2022) The National Consensus statement on the management of adult patients with non-alcoholic fatty liver disease and main comorbidities. Terapevticheskii arkhiv 94:2, pages 216-253.
Crossref
Crossref
Ji Won Yoon, Min Joo Kim, Goh-Eun Chung, Jong In Yang, Jeong Yoon Yim, Jin Ju Kim, Sun Mie Kim & Min-Sun Kwak. (2021) Hepatic fibrosis is associated with an increased rate of decline in bone mineral density in men with nonalcoholic fatty liver disease. Hepatology International 15:6, pages 1347-1355.
Crossref
Crossref
Yoseph Asmelash Gebru, Haripriya Gupta, Hyeong Seop Kim, Jung A. Eom, Goo Hyun Kwon, Eunju Park, Jin-Ju Jeong, Sung-Min Won, Satya Priya Sharma, Raja Ganesan, Dong Joon Kim & Ki Tae Suk. (2021) T Cell Subsets and Natural Killer Cells in the Pathogenesis of Nonalcoholic Fatty Liver Disease. International Journal of Molecular Sciences 22:22, pages 12190.
Crossref
Crossref
Dalal Al-Akabi & Faris S. Kata. (2021) Effect of Non-alcoholic Fatty Liver Disease on Some of Bone Biomarkers in Men. Open Access Macedonian Journal of Medical Sciences 9:A, pages 924-927.
Crossref
Crossref
Zhixiao Luo, Yaqi Wang, Mengzhen Xue, Fangqi Xia, Leiqi Zhu, Yuanyang Li, Dengke Jia, Silong Chen, Guangfu Xu & Yan Lei. (2021) Astragaloside IV ameliorates fat metabolism in the liver of ageing mice through targeting mitochondrial activity. Journal of Cellular and Molecular Medicine 25:18, pages 8863-8876.
Crossref
Crossref
Fangli Zhou, Yan Wang, Yujue Li, Mengjia Tang, Shan Wan, Haoming Tian & Xiang Chen. (2021) Decreased Sclerostin Secretion in Humans and Mice With Nonalcoholic Fatty Liver Disease. Frontiers in Endocrinology 12.
Crossref
Crossref
Ying Huai, Wen-juan Zhang, Wei Wang, Kai Dang, Shan-feng Jiang, Dan-ming Li, Meng Li, Qiang Hao, Zhi-ping Miao, Yu Li & Ai-rong Qian. (2021) Systems pharmacology dissection of action mechanisms for herbs in osteoporosis treatment. Chinese Herbal Medicines 13:3, pages 313-331.
Crossref
Crossref
Kazuhiro Kashiwagi, Michiyo Takayama, Hitoshi Ichikawa, Hiromasa Takaishi, Yasushi Iwao & Takanori Kanai. (2021) A significant association of non-obese non-alcoholic fatty liver disease with osteosarcopenic obesity in females 50 years and older. Clinical Nutrition ESPEN 42, pages 166-172.
Crossref
Crossref
Young Joo Yang & Dong Joon Kim. (2021) An Overview of the Molecular Mechanisms Contributing to Musculoskeletal Disorders in Chronic Liver Disease: Osteoporosis, Sarcopenia, and Osteoporotic Sarcopenia. International Journal of Molecular Sciences 22:5, pages 2604.
Crossref
Crossref
Lara Caserza, Matteo Casula, Edorado Elia, Aldo Bonaventura, Luca Liberale, Maria Bertolotto, Nathan Artom, Silvia Minetti, Paola Contini, Daniela Verzola, Roberto Pontremoli, Franesca Viazzi, Giorgio L. Viviani, Stefano Bertolini, Aldo Pende, Livia Pisciotta, Fabrizio Montecucco & Federico Carbone. (2020) Serum osteopontin predicts glycaemic profile improvement in metabolic syndrome: A pilot study. European Journal of Clinical Investigation 51:3.
Crossref
Crossref
Doaa El Amrousy & Dalia El-Afify. (2020) Osteocalcin and osteoprotegerin levels and their relationship with adipokines and proinflammatory cytokines in children with nonalcoholic fatty liver disease. Cytokine 135, pages 155215.
Crossref
Crossref
Mohsen Nikseresht, Nahid Azarmehr, Arash Arya, Behnam Alipoor, Reza Fadaei, Bahman Khalvati, Hassan Abidi & Amir Hossein Doustimotlagh. (2020) Circulating mRNA and plasma levels of osteoprotegerin and receptor activator of NF‐κB ligand in nonalcoholic fatty liver disease. Biotechnology and Applied Biochemistry.
Crossref
Crossref
Naga S. Samji, Rajanshu Verma & Sanjaya K. Satapathy. (2019) Magnitude of Nonalcoholic Fatty Liver Disease: Western Perspective. Journal of Clinical and Experimental Hepatology 9:4, pages 497-505.
Crossref
Crossref
Wei Zou, Nidhi Rohatgi, Jonathan R. Brestoff, Yan Zhang, Erica L. Scheller, Clarissa S. Craft, Michael D. Brodt, Nicole Migotsky, Matthew J. Silva, Charles A. Harris & Steven L. Teitelbaum. (2019) Congenital lipodystrophy induces severe osteosclerosis. PLOS Genetics 15:6, pages e1008244.
Crossref
Crossref